IsoRay (ISR) Says GliaSite System Received CE Mark; to Go On Sale in 31 European Markets

IsoRay Inc. (AMEX: ISR), announced that the GliaSite radiation therapy system has earned the European CE Mark, allowing immediate sale in 31 European countries. The system’s balloon catheter is a landmark technology that allows physicians to treat more patients than ever before with brachytherapy or internal radiation and provides important benefits over other radiation treatment options.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tempus AI gets FDA clearance for ECG-based AI pulmonary hypertension tool
• KOMO anchors vote to end SAG-AFTRA union representation
• Wendy's names former McDonald's executive as new marketing chief